Showing results (81-90 of 126) with videos related to
Sort By:
Pageof 13
Scientific Reports|March 20, 2019
Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5pBenjamin Goeppert, Felicia Truckenmueller, Alessandro Ori, et al.Journal of Clinical Pathology|May 15, 2024
Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigmThomas Albrecht, Annik Rossberg, Fabian Rose, et al.Annals of Surgery|July 5, 2022
Completion Pancreatectomy After Pancreatoduodenectomy: Who Needs It?Martin Loos, Anna-Katharina König, Nikolai von Winkler, et al.Hepatology (Baltimore, Md.)|September 5, 2013
Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathwayBenjamin Goeppert, Carolin Konermann, Christopher Roman Schmidt, et al.Oncogene|February 15, 2020
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesisSarah Luiken, Angelika Fraas, Matthias Bieg, et al.BMC Cancer|December 7, 2019
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesisThomas Albrecht, Melina Rausch, Stephanie Rössler, et al.Cell Death & Disease|October 29, 2024
Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT/ERK signalingRaisatun Nisa Sugiyanto, Carmen Metzger, Aslihan Inal, et al.International Journal of Cancer|January 12, 2024
N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomasTiemo S Gerber, Dirk A Ridder, Benjamin Goeppert, et al.Gut|January 20, 2021
Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesisBenjamin Goeppert, Damian Stichel, Reka Toth, et al.Virchows Archiv : an International Journal of Pathology|December 16, 2019
HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinomaThomas Albrecht, Melina Rausch, Stephanie Roessler, et al.Pageof 13